Elevation Oncology (ELEV) Institutional Ownership → Look Who Fired the World’s Richest Man (From Banyan Hill Publishing) (Ad) Free ELEV Stock Alerts $3.77 +0.04 (+1.07%) (As of 09:30 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Elevation Oncology (NASDAQ:ELEV)CurrentInstitutional OwnershipPercentage83.70%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$24.79MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$2.28M Get ELEV Insider Trade Alerts Want to know when executives and insiders are buying or selling Elevation Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELEV Institutional Buying and Selling by Quarter Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. Elevation Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2024venBio Partners LLC2,696,133$13.83M4.9%-7.5%4.934% 5/15/2024Darwin Global Management Ltd.2,332,928$11.97M1.6%N/A4.270% 5/15/2024 Affinity Asset Advisors LLC1,268,825$6.51M0.8%N/A2.322% 5/10/2024 Vanguard Group Inc.1,532,045$7.86M0.0%+30.8%2.804% 5/7/2024 SG Americas Securities LLC12,244$63K0.0%N/A0.022% 11/15/2023Armistice Capital LLC750,000$497K0.0%-68.7%1.768% Get the Latest News and Ratings for ELEV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter. 8/15/2023Sphera Funds Management LTD.900,000$1.37M0.2%N/A2.124% 8/15/2023Caxton Corp21,725$33K0.1%-68.2%0.051% 8/11/2023 Velan Capital Investment Management LP497,299$756K0.7%N/A1.173% 8/11/2023 ExodusPoint Capital Management LP1,499,319$2.28M0.0%N/A6.160% 5/15/2023Sio Capital Management LLC876,611$1.67M0.8%+143.7%3.685% 5/1/2023Virtu Financial LLC27,286$52K0.0%N/A0.115% 2/15/2023Tang Capital Management LLC479,854$456K0.1%N/A2.059% 2/13/2023 BML Capital Management LLC39,963$38K0.0%N/A0.172% 11/14/2022Annandale Capital LLC30,000$34K0.0%N/A0.129% 11/14/2022Cormorant Asset Management LP1,952,032$2.21M0.2%-1.6%8.377% 8/16/2022venBio Partners LLC1,866,339$2.61M0.7%-28.4%8.013% 8/10/2022Kennedy Capital Management Inc.149,893$210K0.0%+968.4%0.644% 4/26/2022 Marquette Asset Management LLC38,951$98K0.0%+332.5%0.168% 4/25/2022 Bailard Inc.23,500$59K0.0%N/A0.101% 2/18/2022TCG Crossover Management LLC555,000$3.34M1.6%N/A2.389% 2/15/2022Kennedy Capital Management Inc.15,485$93K0.0%N/A0.067% 2/14/2022Boxer Capital LLC872,780$5.25M0.2%-34.9%3.758% 2/14/2022Sio Capital Management LLC250,000$1.51M0.5%N/A1.076% 1/19/2022 Marquette Asset Management LLC9,006$54K0.0%N/A0.039% 11/16/2021Schonfeld Strategic Advisors LLC18,044$141K0.0%-29.8%0.078% 11/16/2021Janus Henderson Group PLC1,220,205$9.38M0.0%+18.3%5.254% 11/16/2021Caxton Corp48,183$375K0.3%+21.7%0.207% 11/9/2021 BlackRock Inc.23,837$186K0.0%N/A0.103% 8/17/2021 Weiss Multi Strategy Advisers LLC15,037$204K0.0%N/A0.066% 8/17/2021Woodline Partners LP112,431$1.53M0.0%N/A0.493% 8/17/2021Samsara BioCapital LLC932,239$12.65M1.6%N/A4.085% 8/17/2021Sphera Funds Management LTD.30,000$407K0.0%N/A0.131% 8/17/2021Millennium Management LLC123,062$1.67M0.0%N/A0.539% 8/17/2021BVF Inc. IL1,590,291$21.58M0.8%N/A6.968% 8/17/2021Boxer Capital LLC1,341,530$18.21M0.6%N/A5.878% 8/17/2021 Caas Capital Management LP60,000$814K0.0%N/A0.263% 8/17/2021Caxton Corp39,586$537K0.4%N/A0.173% 8/16/2021LMR Partners LLP31,300$425K0.0%N/A0.137% 8/16/2021Point72 Asset Management L.P.50,000$679K0.0%N/A0.219% Democrats Push to Replace Dollar With Digital Coin, Control Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late.8/16/2021venBio Partners LLC2,608,167$35.39M4.2%N/A11.428% 8/16/2021Alyeska Investment Group L.P.125,000$1.70M0.0%N/A0.548% 8/16/2021Schonfeld Strategic Advisors LLC25,700$349K0.0%N/A0.113% 8/16/2021Pinz Capital Management LP36,400$494K0.1%N/A0.159% 8/16/2021 Maven Securities LTD16,000$204K0.0%N/A0.070% 8/16/2021Goldman Sachs Group Inc.62,500$848K0.0%N/A0.274% 8/13/2021 Northern Trust Corp4,803$65K0.0%N/A0.021% 8/13/2021 Qube Research & Technologies Ltd24,255$329K0.0%N/A0.106% 8/13/2021 Vanguard Group Inc.60,000$814K0.0%N/A0.263% 8/12/2021 Monashee Investment Management LLC140,000$1.90M0.2%N/A0.613% 8/11/2021Ghost Tree Capital LLC100,000$1.36M0.4%N/A0.438% (Data available from 1/1/2016 forward) ELEV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELEV shares? During the previous two years, 17 institutional investors and hedge funds held shares of Elevation Oncology. The most heavily invested institutionals were venBio Partners LLC ($13.83M), Darwin Global Management Ltd. ($11.97M), Vanguard Group Inc. ($7.86M), Affinity Asset Advisors LLC ($6.51M), ExodusPoint Capital Management LP ($2.28M), Cormorant Asset Management LP ($2.21M), and Sio Capital Management LLC ($1.67M).Learn more on ELEV's institutional investors. What percentage of Elevation Oncology stock is owned by institutional investors? 83.70% of Elevation Oncology stock is owned by institutional investors. Learn more on ELEV's institutional investor holdings. Which institutional investors have been buying Elevation Oncology stock? Of the 13 institutional investors that purchased Elevation Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Darwin Global Management Ltd. ($2.33M), ExodusPoint Capital Management LP ($1.50M), Affinity Asset Advisors LLC ($1.27M), Sphera Funds Management LTD. ($900K), Sio Capital Management LLC ($516.88K), Velan Capital Investment Management LP ($497.30K), and Tang Capital Management LLC ($479.85K). How much institutional buying is happening at Elevation Oncology? Institutional investors have bought a total of 8,101,260 shares in the last 24 months. This purchase volume represents approximately $26.55M in transactions. Which Elevation Oncology major shareholders have been selling company stock? The following institutional investors have sold Elevation Oncology stock in the last 24 months: Armistice Capital LLC ($1.65M), venBio Partners LLC ($959.95K), Caxton Corp ($46.60K), and Cormorant Asset Management LP ($31.14K). How much institutional selling is happening at Elevation Oncology? Institutional investors have sold a total of 2,683,685 shares in the last 24 months. This volume of shares sold represents approximately $3.35M in transactions. Related Companies: CGEN Major Shareholders OPT Major Shareholders XFOR Major Shareholders ZURA Major Shareholders ABOS Major Shareholders INMB Major Shareholders GNFT Major Shareholders CLLS Major Shareholders KOD Major Shareholders IPHA Major Shareholders This page (NASDAQ:ELEV) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
